Description
The debate proposed Akkermansia-mediated barrier dysfunction triggers alpha-synuclein propagation, but the molecular mechanisms of mucin degradation and tight junction disruption remain undefined. This limits targeted therapeutic development.
Source: Debate session sess_sda-2026-04-01-gap-20260401-225149 (Analysis: sda-2026-04-01-gap-20260401-225149)